SAMHSA and NIDA Convene Summit on Buprenorphine Treatment

The Summit convened February 21-22, 2008, in Washington, D.C. to bring together experts in
epidemiology, pharmacology, toxicology, and addiction treatment in order to build upon the findings
of the previous summits in 2003 and 2005. Participants assessed the successes, progress and
continued barriers to access to opioid treatment with buprenorphine. Presentations identified best
practices and useful clinical supports to enhance the quality of treatment. Participants identified
strategies to address emerging issues and concerns. SAMHSA and NIDA will prepare a report on the
proceedings.